
NeogenTC
Developer of cancer therapies designed to provide personalized anticancer treatment. The company's solution, based on a novel antigen discovery platform, combines with actual immune cells beyond inacc...
Valuation
$0
Share Price
N/A
Total Raised
$13.7M
Last Round
N/A